Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
The Journal of Experimental Medicine
|
August 8, 2001
Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module
N Engels, M Merchant, R Pappu, et al.
Virology
|
November 2, 2001
The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1
C W Dawson, J H George, S M Blake, et al.
Archives of Virology
|
January 1, 1997
In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2)
R Rochford, C L Miller, M J Cannon, et al.
Infectious Agents and Disease
|
April 1, 1994
Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction
C L Miller, J H Lee, E Kieff, et al.
Journal of Virology
|
November 13, 1999
An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation
K M Kaye, K M Izumi, H Li, et al.
Experimental Cell Research
|
June 6, 2000
WW- and SH3-domain interactions with Epstein-Barr virus LMP2A
R Longnecker, M Merchant, M E Brown, et al.
Cell
|
June 28, 1991
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
S Henderson, M Rowe, C Gregory, et al.
Journal of Virology
|
September 1, 1996
Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
S Fruehling, S K Lee, R Herrold, et al.
Immunity
|
February 1, 1995
Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
C L Miller, A L Burkhardt, J H Lee, et al.
International Reviews of Immunology
|
March 27, 2002
The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function
M Merchant, R Swart, R B Katzman, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
The Journal of Experimental Medicine
|
August 8, 2001
Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module
N Engels, M Merchant, R Pappu, et al.
Virology
|
November 2, 2001
The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1
C W Dawson, J H George, S M Blake, et al.
Archives of Virology
|
January 1, 1997
In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2)
R Rochford, C L Miller, M J Cannon, et al.
Infectious Agents and Disease
|
April 1, 1994
Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction
C L Miller, J H Lee, E Kieff, et al.
Journal of Virology
|
November 13, 1999
An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation
K M Kaye, K M Izumi, H Li, et al.
Experimental Cell Research
|
June 6, 2000
WW- and SH3-domain interactions with Epstein-Barr virus LMP2A
R Longnecker, M Merchant, M E Brown, et al.
Cell
|
June 28, 1991
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
S Henderson, M Rowe, C Gregory, et al.
Journal of Virology
|
September 1, 1996
Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
S Fruehling, S K Lee, R Herrold, et al.
Immunity
|
February 1, 1995
Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
C L Miller, A L Burkhardt, J H Lee, et al.
International Reviews of Immunology
|
March 27, 2002
The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function
M Merchant, R Swart, R B Katzman, et al.
Page
of 7